期刊文献+

生物可降解5-氟尿嘧啶载药微球的制备及性能研究 被引量:17

Preparation and Properties of Biodegradable Microspheres Containing 5-Fluorouracil
在线阅读 下载PDF
导出
摘要 Microspheres containing an antimetabolite drug 5-Fluorouracil were prepared from (poly(lactic) acide)(PLA) or poly(lactic acid)-polyethylene glycol(PLA-PEG) as the carrier by using a water-in-oil-in-water emulsion solvent evaporation technique. The conditions of the microspheres preparation such as polymer concentration in organic solvent, relative molecular weight of PLA-PEG and PLA/PEG mass ratio were discussed. The surface morphology and the size of the microspheres were observed by SEM. The drug content of microspheres was examined by TGA and the drug release in vitro was evaluated. According to the results, the drug content increased with the nano-silica used. The highest drug content in this study was 39.9%. The drug-release kinetics satisfied the requirements of controlled drug-release. Microspheres containing an antimetabolite drug 5-Fluorouracil were prepared from (poly(lactic) acide)(PLA) or poly(lactic acid)-polyethylene glycol(PLA-PEG) as the carrier by using a water-in-oil-in-water emulsion solvent evaporation technique. The conditions of the microspheres preparation such as polymer concentration in organic solvent, relative molecular weight of PLA-PEG and PLA/PEG mass ratio were discussed. The surface morphology and the size of the microspheres were observed by SEM. The drug content of microspheres was examined by TGA and the drug release in vitro was evaluated. According to the results, the drug content increased with the nano-silica used. The highest drug content in this study was 39.9%. The drug-release kinetics satisfied the requirements of controlled drug-release.
出处 《高等学校化学学报》 SCIE EI CAS CSCD 北大核心 2005年第6期1174-1176,共3页 Chemical Journal of Chinese Universities
基金 国家自然科学基金(批准号:50473061)资助.
关键词 5-氟尿嘧啶 聚乳酸(PLA) 乳酸-乙二醇(PLA—PEG) 微球 纳米二氧化硅 控制药物释放 5-Fluorouracil Poly(lactic acide)(PLA) Poly(lactic acid)-polyethylene glycol(PLA-PEG) Microspheres Nano-silica Controlled drug-release
  • 相关文献

参考文献12

  • 1Pinedo H. M., Peters G. F.. J. Clin. Oncol.[M], 1988, 6: 1653-1664.
  • 2Hazrati A. M., Deluca P. P.. Proc. Int. Symp. Contr. Rel. Bioact. Mater.[J], 1989, 16: 79-80.
  • 3Zinutti C., Kedzierewiez F., Hoffman M. et al.. J. Microenc.[J], 1994, 11: 555-563.
  • 4Elvire Fourniera, Catherine Passirani, Nathalie Colin et al.. Eur. J. Pharm Biopharm[J], 2004, 57: 189-197.
  • 5Fu Y. J., Shyu S. S., Su F. H. et al.. Colloids and Surfaces B[J], 2002, 25: 269-279.
  • 6卓仁禧,王均,毛海泉.聚磷酸酯-聚氨酯药物释放材料的合成[J].高等学校化学学报,1997,18(7):1207-1211. 被引量:12
  • 7张万国,蒋雪涛.利福平聚乳酸微球的制备[J].第二军医大学学报,1996,17(4):395-397. 被引量:9
  • 8Mogi Takao, Ohtake Naoko, Yoshida Masaru et al.. Colloids and Surfaces B: Biointerfaces[J], 2000, 17(3): 153-165.
  • 9Ruan G., Feng S. S.. Biomaterials[J], 2003, 24: 5037-5044.
  • 10杨亚楠,娄玲,梁奇志,陈学思,景遐斌.生物降解聚酯包埋利福平缓释微球的制备及释放行为[J].高等学校化学学报,2004,25(1):162-165. 被引量:32

二级参考文献15

  • 1毛海泉,卓仁禧,范昌烈,樊李红,付亚平.新型聚磷酸酯药物控释材料的合成[J].高等学校化学学报,1993,14(12):1743-1747. 被引量:6
  • 2沈正荣,朱家蕙,吴兰亭,肖银林,程敬亮,吴自伦,李树新.5-氟尿嘧啶聚乳酸微球制备及体内外释药特性的研究[J].中国医药工业杂志,1995,26(7):306-309. 被引量:22
  • 3张万国,蒋雪涛.利福平聚乳酸微球的制备[J].第二军医大学学报,1996,17(4):395-397. 被引量:9
  • 4王剑红 陆彬 胥佩菱.Acta Pharmaceutica Sinica(药学学报)[J],1995,30:549-553.
  • 5崔一民 鲁云兰.Chinese Journal of Hospital Pharmacy(中国医院药学杂志)[J],1999,19(3):66-70.
  • 6刘群 薛伟明 于炜婷.Chem. J.Chinese Universities(高等学校化学学报)[J],2002,23(7):1-1.
  • 7王海波 刘德山.Chem. J.Chinese Universities(高等学校化学学报)[J],2002,23(9):1-1.
  • 8Cifltci K, Kas HS, Hincal AA, et al. In vitro and in vivo evaluation of PLAGA(50/50) microspheres containing 5-fluorouracil prepared by a solvent evaporation method[J].Int J Pharm, 1996,131(1 ) : 73-82.
  • 9Hagiwara A, Takahashi T, Sawai K, et al. Pharmacological effect of 5-fluorouracil microspheres on peritoneal carcinomatosis in animals [J]. Brit J Cancer,1996,74,1392-1396.
  • 10张明,药学学报,1994年,29卷,5期,38页

共引文献52

同被引文献240

引证文献17

二级引证文献170

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部